Sep 25, 2017 - RBC Capital Mkts issues rating change for AGN
Sep 15, 2017 - Looking for income from the healthcare sector? Here's why you should check out Gilead Sciences, Allergan, and LeMaitre Vascular.
Sep 15, 2017 - The FDA has approved Amgen and Allergan's Mvasi, the first-ever cancer-drug biosimilar to win an OK.
Sep 29, 2017 - Investor presentations at conferences this week boosted optimism that Trulance is gaining market share.
Oct 02, 2017 - Barclays issues rating change for AGN
Oct 05, 2017 - Solid current franchises and strong pipelines could make these three big pharma stocks big winners in coming years.
Oct 06, 2017 - Allergan continues to be a victim of Teva's downfall.
Oct 11, 2017 - Mylan's latest drug approval could take a big chunk out of Teva Pharmaceutical's revenue.
Oct 14, 2017 - Good news from clinical studies and a scrapped acquisition help powered these biotech stocks to huge gains this week.
Oct 17, 2017 - Allergan Inc. (AGN) sold off sharply Monday afternoon, after the U.S. District Court for the Eastern District of Texas ruled that four asserted patents covering RESTASIS 0.05% are invalid.